| Filed On | Filing |
|---|---|
| 12 Nov 2026 |
Form 4: Frederick Wayne A.i., Director
Sold 440 shares ($194K) |
| 12 Nov 2026 |
Form 4: Dintenfass David, President, Enterprise Growth
Gave 230 shares as a gift |
| 12 Nov 2026 |
Form 4: Ventura Joseph C, Chief Legal Officer
Sold 5,495 shares ($2.38M) · Gave 437 shares as a gift |
| 10 Nov 2026 | 144 |
| 09 Nov 2026 |
8-K: Other Events
Louisville, KY - November 9, 2026 – Humana Inc. (NYSE: HUM) (“Humana”, “we”, or “our”) today announced that it has commenced cash tender offers (collectively, the “Offers”) to purchase the outstanding notes described below, in each case ... |
| 09 Nov 2026 | 144 |
| 06 Nov 2026 | 10-Q |
| 06 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
LOUISVILLE, KY (November 6, 2026) – Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share for the quarter ended September 30, 2026 (3Q26) versus the quarter ended September 30, 2025 (3Q25) and ... |
| 13 Oct 2026 |
8-K: Regulation FD Disclosure
Investors: Lisa Stoner - Humana Investor Relations; (502) 580-2652; |
| 09 Oct 2026 |
8-K: Regulation FD Disclosure
Supplementary audio commentary from Humana’s President and Chief Executive Officer, Jim Rechtin, may be accessed via Humana’s Investor Relations page at https://humana.gcs-web.com/. |
| 02 Oct 2026 |
Form 4: Hilzinger Kurt J, Director
Granted 238 Restricted Stock Units ($91.6K) |
| 03 Sep 2026 |
Form 4: Nundy Shantanu, Chief Medical Officer
Received 2,549 shares as a grant or award |
| 01 Sep 2026 |
8-K: Regulation FD Disclosure
Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at various meetings between September 1, 2026 and September 30, 2026. During these meetings, the Company intends to reaffir... |
| 31 Aug 2026 |
Form 3: Nundy Shantanu, Chief Medical Officer
Holds 0 shares of Humana Common |
| 04 Aug 2026 |
Form 4: Smith Paul John, Director
Received 544 shares as a grant or award |
| 04 Aug 2026 |
Form 4: Crawford Frederick John, Director
Received 544 shares as a grant or award |
| 29 Jul 2026 | 10-Q |
| 29 Jul 2026 |
Form 3: Crawford Frederick John, Director
Holds 21 shares of Humana Common |
| 29 Jul 2026 |
Form 3: Smith Paul John, Director
Holds 0 shares of Humana Common |
| 29 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Mark Taylor - Humana Corporate Communications; (317) 753-0345; |
Loading...